GATA1 and Diamond-Blackfan anemia: We previously showed that increasing the expression of GATA1 in bone marrow samples from patients with DBA is sufficient to overcome the erythroid differentiation defects in vitro14, suggesting that restoration of sufficient GATA1 protein levels could be a therapeutic avenue for DBA patients regardless of the underlying genotype.